FDA Opens Comment Period for Revised Guidance on Drug-Induced Liver Injury, Hosts Public Conference

Summary

The FDA, in collaboration with the American Association for the Study of Liver Diseases and the Pharmaceutical and Research Manufacturers of America, is seeking public input on revising its 2009 guidance on drug-induced liver injury, with a public conference scheduled for March 24-25, 2010.